Koers Medical Prognosis Institute A/S Nasdaq Copenhagen
Aandelen
MPIT
DK0060732477
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 8,24 mln. 57,49 mln. 7,7 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -16 mln. -112 mln. -14,96 mln. | Nettowinst (verlies) 2025 * | -28 mln. -195 mln. -26,18 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,18
x | K/w-verhouding 2025 * |
-0,3
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Medical Prognosis Institute A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 01-06-20 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-21 |
Chief Tech/Sci/R&D Officer | 63 | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 56 | 01-10-22 | |
Thomas Jensen
FOU | Founder | 46 | 01-06-20 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 01-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,40% | 124 mld. | |
+18,01% | 111 mld. | |
-11,84% | 23,17 mld. | |
+5,07% | 22,94 mld. | |
-39,94% | 17,42 mld. | |
-10,19% | 17,42 mld. | |
-14,97% | 16,9 mld. | |
+2,57% | 13,71 mld. | |
+26,96% | 11,82 mld. |